FDA finds safety issues at specialty pharmacies, pushes for oversight

Posted in Drug & Medical Devices on April 14, 2013

Specialty pharmacies have been in the news several times in recent months. First was the deadly fungal meningitis outbreak last October that was linked to contaminated steroids from the New England Compounding Center. Then last month, a New Jersey compounding pharmacy issued a nationwide recall of all its products due to a mold risk...